Long-acting amylin analogue for weight management
The Lancet · 2021
A phase 2 trial of a once-weekly amylin analogue reported dose-dependent weight reduction relative to placebo, with effects attributed to satiety and gastric emptying signalling.
peptides
Cagrilintide5mg
$74.99
A long-acting amylin analogue studied alongside incretin compounds in satiety and metabolic research models.
- Purity
- ≥99% (HPLC)
- Form
- Lyophilized powder
- Vial
- 5mg
- Testing
- Third-party assayed
1
- Free shipping on orders $199+
- Unbranded, discreet packaging
From the literature
Cagrilintide research
Research articles about Cagrilintide
Amylin and incretin co-administration
Nature Metabolism · 2023
Combination research shows amylin receptor agonism acts through a receptor complex separate from GLP-1, producing additive effects on food intake in preclinical and early clinical models.
Summaries of published literature, provided for context only. Nothing here is medical advice, and this product is sold for laboratory research use only.
Pairs well with
Related research
Related products
Retatrutide 10mg
$89.99Triple-agonist research compound.
Tirzepatide 10mg
$59.99Dual-agonist metabolic research.
BPC-157 5mg
$49.99Body protection compound.
GHK-Cu 50mg
$54.99Copper tripeptide complex.
Cagrilintide
$74.99